In this prospective randomized , double-blind , placebo-controlled study , @ CHB patients with PNALT were screened , @ patients received biopsy and @ patients met the HBV DNA and histology criteria and were randomly assigned to either an entecavir or placebo group for @ weeks , with @ and @ in each group , respectively .